Regencell Bioscience Holdings Limited (RGC) Earning

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$20
Day's range
$29.01

Regencell Bioscience Holdings Ltd Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2025 Q4 2025 N/A -$0.00 N/A N/A $0
12/29/2024 Q2 2025 N/A -$0.14 N/A N/A $0
06/29/2024 Q4 2024 N/A $0.00 N/A N/A $0
12/29/2023 Q2 2024 N/A -$0.00 N/A N/A $0
06/30/2023 Q4 2023 N/A -$0.01 N/A N/A $0
12/30/2022 Q2 2023 N/A -$0.01 N/A N/A $0
06/30/2022 Q4 2022 N/A -$0.01 N/A N/A $-2,341,800,000
12/30/2021 Q2 2022 N/A -$0.01 N/A N/A $0
06/30/2021 Q4 2021 N/A -$0.00 N/A N/A $0
12/30/2020 Q2 2021 N/A -$0.00 N/A N/A $0
06/30/2020 Q4 2020 N/A -$0.00 N/A N/A $0
12/30/2019 Q2 2020 N/A -$0.00 N/A N/A $0

Regencell Bioscience Holdings Ltd Earnings: FAQ's

The conference call for Regencell Bioscience Holdings Ltd's latest earnings report can be listened to online.

The conference call transcript for Regencell Bioscience Holdings Ltd's latest earnings report can be read online.

Regencell Bioscience Holdings Ltd (:RGC) has a recorded net income of $-3,584,213.Regencell Bioscience Holdings Ltd has generated $-0.0072 earnings per share over the last four quarters.

Regencell Bioscience Holdings Ltd (:RGC) has a price-to-earnings ratio of -3976.09 and price/earnings-to-growth ratio is -39.76.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED